Laboratory‐confirmed reinfections with Bordetella pertussis

Susceptibility to infection with Bordetella pertussis re‐emerges several years after pertussis vaccination. However, the duration of immunity after natural infection with B. pertussis, postulated to be lifelong, is not known. In an ongoing study, the longitudinal course of pertussis antibodies in patients who have had laboratory‐confirmed pertussis is being followed using sera obtained at irregular intervals. In 4 patients a reinfection with Bordetella pertussis is described respectively 7 (patient A), 12 (patients B and C) and 3.5 (patient D) y after the first infection. It seems that the longer the interval between the infections the more severe the complaints.

[1]  J. A. Hunt,et al.  Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. , 2001, The Journal of infectious diseases.

[2]  J. Schellekens,et al.  Specificity and Sensitivity of High Levels of Immunoglobulin G Antibodies against Pertussis Toxin in a Single Serum Sample for Diagnosis of Infection with Bordetella pertussis , 2000, Journal of Clinical Microbiology.

[3]  H. Hethcote,et al.  Simulations of pertussis epidemiology in the United States: effects of adult booster vaccinations. , 1999, Mathematical biosciences.

[4]  S. Deeks,et al.  Failure of physicians to consider the diagnosis of pertussis in children. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  H. Schmitt,et al.  A serologic study of organisms possibly associated with pertussis-like coughing. , 1998, The Pediatric infectious disease journal.

[6]  F. Mooi,et al.  Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine. , 1997, Emerging infectious diseases.

[7]  F. Mooi,et al.  A clinical validation of Bordetella pertussis and Bordetella parapertussis polymerase chain reaction: comparison with culture and serology using samples from patients with suspected whooping cough from a highly immunized population. , 1996, The Journal of infectious diseases.

[8]  H. Schmitt,et al.  Pertussis in adults: frequency of transmission after household exposure , 1995, The Lancet.

[9]  S. Long,et al.  Serologic evidence of subclinical pertussis in immunized children , 1990, The Pediatric infectious disease journal.

[10]  S. Long,et al.  Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. , 1990, The Journal of infectious diseases.

[11]  D. Jenkinson.  Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study , 1988, British medical journal.

[12]  J. W. Bass.  Erythromycin for treatment and prevention of pertussis , 1986, Pediatric infectious disease.

[13]  S. de Graaf,et al.  Improved serodiagnosis of whooping cough caused by Bordetella pertussis by determination of IgG anti-LPF antibody levels. , 1985, Developments in biological standardization.

[14]  J. Nagel,et al.  Serum IgA antibody to Bordetella pertussis as an indicator of infection. , 1983, Journal of medical microbiology.

[15]  M. Hay,et al.  Whooping-cough: Its prevalence and mortality in Aberdeen , 1901 .